Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for us
Short Description: Onc dx esophag t1-t3 noprog
Coverage Code: Carrier judgment
Action Code: No maintenance for this code
Date Added: January 1, 2006
Effective Date: January 1, 2007
Termination Date: